Liangji Zhou

Chinese University of Hong Kong — China

Medicine · Health Sciences

4h-index38citations6works4.02yr avg

OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastrointestinal Tumor Research and Treatment(2), MicroRNA in disease regulation(1), SARS-CoV-2 and COVID-19 Research(1), Advanced biosensing and bioanalysis techniques(1), Sarcoma Diagnosis and Treatment(1)

Publications6 total

RAF1 facilitates KIT signaling and serves as a potential treatment target for gastrointestinal stromal tumor

2 cited

Oncogene·2024· 2 cited

ZSWIM4 regulates embryonic patterning and BMP signaling by promoting nuclear Smad1 degradation

6 cited

EMBO Reports·2024· 6 citedOpen Access

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib

9 cited

Gastric Cancer·2023· 9 citedOpen Access

CRISPR‐Cas13d effectively targets SARS‐CoV‐2 variants, including Delta and Omicron, and inhibits viral infection

10 cited

MedComm·2023· 10 citedOpen Access

Genome-wide identification and spatiotemporal expression profiling of zinc finger SWIM domain-containing protein family genes

10 cited

动物学研究·2023· 10 citedOpen Access

ZSWIM4 regulates early embryonic patterning and BMP signaling pathway by promoting nuclear Smad1 degradation

1 cited

Research Square (Research Square)·2022· 1 citedOpen Access

Frequent Co-authors

Hui Zhao(6), Chengdong Wang(4), Jianmin Sun(4), Ziran Liu(3), Xufeng Qi(3), Imtiaz Ul Hassan(2), Sien Zhao(2), Shaoting Zhang(2), Liangying Zhang(2), Xu Cao(2), Jinhai Tian(2), Yuanyuan Yu(2), Kun Xiao(2), Ming Wang(2), Yelin Zeng(2), Qi Long(2), Dongqing Cai(2), Bingyu Mao(2), Gang Lü(2), Yong‐Gang Yao(2)